{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:30:35Z","timestamp":1789183835588,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":603,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development (AMED)","doi-asserted-by":"publisher","award":["JP18fk0410015"],"award-info":[{"award-number":["JP18fk0410015"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science (JSPS)","doi-asserted-by":"publisher","award":["JP16K08826"],"award-info":[{"award-number":["JP16K08826"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012319","name":"National Center for Global Health and Medicine (NCGM)","doi-asserted-by":"publisher","award":["2921010"],"award-info":[{"award-number":["2921010"]}],"id":[{"id":"10.13039\/100012319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute (NCI)","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1074\/jbc.ra118.005798","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T10:37:24Z","timestamp":1542019044000},"page":"116-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C\u2013induced HIV latency reversal"],"prefix":"10.1016","volume":"294","author":[{"given":"Kouki","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kobayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoto","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Gatanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Tamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Mitsuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9424-1491","authenticated-orcid":false,"given":"Kenji","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.005798_bib1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/44755","article-title":"Re-emergence of HIV after stopping therapy","volume":"401","author":"Chun","year":"1999","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.005798_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.005798_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T-cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA118.005798_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1146\/annurev.med.59.062806.123001","article-title":"Hide-and-seek: the challenge of viral persistence in HIV-1 infection","volume":"59","author":"Geeraert","year":"2008","journal-title":"Annu. Rev. Med"},{"key":"10.1074\/jbc.RA118.005798_bib5","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1073\/pnas.1402873111","article-title":"Quantification of HIV-1 latency reversal in resting CD4+ T-cells from patients on suppressive antiretroviral therapy","volume":"111","author":"Cillo","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.005798_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1570162043484915","article-title":"Can HIV be cured? Mechanisms of HIV persistence and strategies to combat it","volume":"2","author":"Hamer","year":"2004","journal-title":"Curr. HIV Res"},{"key":"10.1074\/jbc.RA118.005798_bib7","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/S0140-6736(13)60104-X","article-title":"Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs","volume":"381","author":"Katlama","year":"2013","journal-title":"Lancet"},{"key":"10.1074\/jbc.RA118.005798_bib8","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The challenge of finding a cure for HIV infection","volume":"323","author":"Richman","year":"2009","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.005798_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature11286","article-title":"Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy","volume":"487","author":"Archin","year":"2012","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.005798_bib10","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1016\/S2352-3018(15)00226-X","article-title":"Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study","volume":"2","author":"Elliott","year":"2015","journal-title":"Lancet HIV"},{"key":"10.1074\/jbc.RA118.005798_bib11","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","article-title":"Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial","volume":"1","author":"Rasmussen","year":"2014","journal-title":"Lancet HIV"},{"key":"10.1074\/jbc.RA118.005798_bib12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev-virology-101416-041646","article-title":"Transcriptional control of HIV latency; cellular signaling pathways, epigenetics, happenstance and the hope for a cure","volume":"4","author":"Mbonye","year":"2017","journal-title":"Annu. Rev. Virol"},{"key":"10.1074\/jbc.RA118.005798_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","article-title":"Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure","volume":"155","author":"Ho","year":"2013","journal-title":"Cell"},{"key":"10.1074\/jbc.RA118.005798_bib14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"Bullen","year":"2014","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA118.005798_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4161\/cc.23309","article-title":"BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism","volume":"12","author":"Boehm","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1074\/jbc.RA118.005798_bib16","doi-asserted-by":"crossref","first-page":"42008","DOI":"10.1074\/jbc.M402124200","article-title":"Prostratin antagonizes HIV latency by activating NF-\u03baB","volume":"279","author":"Williams","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005798_bib17","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","article-title":"Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations","volume":"125","author":"Laird","year":"2015","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA118.005798_bib18","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1021\/jm990613q","article-title":"Conformationally constrained analogues of diacylglycerol (DAG). 17. Contrast between sn-1 and sn-2 DAG lactones in binding to protein kinase C","volume":"43","author":"Tamamura","year":"2000","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA118.005798_bib19","doi-asserted-by":"crossref","first-page":"28495","DOI":"10.1074\/jbc.270.48.28495","article-title":"Protein kinase C; structure, function, and regulation","volume":"270","author":"Newton","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.005798_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11904-007-0009-6","article-title":"Confronting proviral HIV infection","volume":"4","author":"Margolis","year":"2007","journal-title":"Curr. HIV\/AIDS Rep"},{"key":"10.1074\/jbc.RA118.005798_bib21","doi-asserted-by":"crossref","first-page":"e1005066","DOI":"10.1371\/journal.ppat.1005066","article-title":"Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-\u03baB signaling in combination with JQ1 induced p-TEFb activation","volume":"11","author":"Jiang","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1074\/jbc.RA118.005798_bib22","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrc2168","article-title":"Targeting the protein kinase C family; are we there yet?","volume":"7","author":"Mackay","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.RA118.005798_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0960-894X(94)80023-5","article-title":"Chiral requirements for tumor promoters: conformations and activity of benzolactams","volume":"4","author":"Endo","year":"1994","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1074\/jbc.RA118.005798_bib24","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/ja953578v","article-title":"Synthesis, conformation and biological activity of teleocidin mimics, benzolactams. A clarification of the conformational flexibility problem in structure-activity studies of teleocidins","volume":"118","author":"Endo","year":"1996","journal-title":"J. Am. Chem. Soc"},{"key":"10.1074\/jbc.RA118.005798_bib25","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1021\/jm970704s","article-title":"Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase C\u03b4 by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation","volume":"41","author":"Endo","year":"1998","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA118.005798_bib26","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1021\/jm050857c","article-title":"Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase C\u03f5 and \u03b7","volume":"49","author":"Nakagawa","year":"2006","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA118.005798_bib27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/jm2011172","article-title":"Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)","volume":"55","author":"Duffey","year":"2012","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.RA118.005798_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cmdc.200500068","article-title":"Synthesis and pharmacological evaluation of 8- and 9-substituted benzolactam-v8 derivatives as potent ligands for protein kinase C, a therapeutic target for Alzheimer's disease","volume":"1","author":"Mach","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1074\/jbc.RA118.005798_bib29","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1248\/bpb.17.1147","article-title":"Teleocidins and benzolactams inhibit cell killing by human immunodeficiency virus type 1 (HIV-1)","volume":"17","author":"Endo","year":"1994","journal-title":"Biol. Pharm. Bull"},{"key":"10.1074\/jbc.RA118.005798_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4690-10-11","article-title":"Cellular and molecular mechanism involved in the establishment of HIV-1 latency","volume":"10","author":"Donahue","year":"2013","journal-title":"Retrovirology"},{"key":"10.1074\/jbc.RA118.005798_bib31","doi-asserted-by":"crossref","first-page":"16646","DOI":"10.1038\/s41598-017-16816-1","article-title":"BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA118.005798_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","article-title":"Getting the \u201cKill\u201d into \u201cShock and Kill\u201d: strategies to eliminate latent HIV","volume":"23","author":"Kim","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1074\/jbc.RA118.005798_bib33","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fmicb.2018.02022","article-title":"Combination of a latency-reversing agents with an smac mimetics minimizes secondary HIV-1 infection in vitro","volume":"9","author":"Hattori","year":"2018","journal-title":"Front. Microbiol"},{"key":"10.1074\/jbc.RA118.005798_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2741\/3232","article-title":"The molecular \u201cJekyll and Hyde\u201d duality of PARP1 in cell death and cell survival","volume":"14","author":"Hassa","year":"2009","journal-title":"Front. Biosci"},{"key":"10.1074\/jbc.RA118.005798_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","article-title":"Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis","volume":"45","author":"Ouyang","year":"2012","journal-title":"Cell Prolif"},{"key":"10.1074\/jbc.RA118.005798_bib36","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1182\/blood-2007-06-097907","article-title":"CCR7 ligands CCL19 and CCL21 increase permissiveness of resting memory CD4+ T-cells to HIV-1 infection: a novel model of HIV-1 latency","volume":"110","author":"Saleh","year":"2007","journal-title":"Blood"},{"key":"10.1074\/jbc.RA118.005798_bib37","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1128\/JVI.00572-15","article-title":"H3K27 demethylation at the proviral promoter sensitizes latent HIV to the effects of vorinostat in ex vivo culture of resting CD4+ T-cells","volume":"89","author":"Tripathy","year":"2015","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.005798_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.chom.2015.08.009","article-title":"BIRC2\/cIAP1 is a negative regulator of HIV-1 transcription and can be targeted by Smac mimetics to promote reversal of viral latency","volume":"18","author":"Pache","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1074\/jbc.RA118.005798_bib39","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1038\/s41598-017-07157-0","article-title":"Reactivation of HIV-1 from latency by an ingenol derivative from euphorbia kansui","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA118.005798_bib40","doi-asserted-by":"crossref","first-page":"10803","DOI":"10.1128\/JVI.00320-14","article-title":"The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T-cells to HIV by increasing the kinetics and efficiency of postentry viral events","volume":"88","author":"Lucera","year":"2014","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA118.005798_bib41","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/emboj\/20.7.1726","article-title":"The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation","volume":"20","author":"Jordan","year":"2001","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA118.005798_bib42","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/emboj\/cdg188","article-title":"HIV reproducibly establishes a latent infection after acute infection of T-cells in vitro","volume":"22","author":"Jordan","year":"2003","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA118.005798_bib43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbrc.2014.12.102","article-title":"Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity","volume":"457","author":"Matsuda","year":"2015","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.RA118.005798_bib44","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1128\/AAC.00270-09","volume":"53","author":"Hattori","year":"2009","journal-title":"Antimicrob. Agents Chemother"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820368848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820368848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.005798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T04:41:49Z","timestamp":1678423309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820368848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0021925820368848"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.005798","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzolactam-related compounds promote apoptosis of HIV-infected human cells via protein kinase C\u2013induced HIV latency reversal","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.005798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}